Statement of Organization, Functions, and Delegations of Authority, 81915-81917 [2024-23316]

Download as PDF Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices khammond on DSKJM1Z7X2PROD with NOTICES Registration The FAR Council is committed to engaging with industry partners and the public with regards to FAR Council policies and issues relevant to current and future Federal Acquisition Regulation cases, including suggestions and concerns with new and existing policies. In addition, the FAR Council is interested in hearing views on topics such as: (1) new laws or draft legislation on which it should focus; (2) how it can improve the acquisition process; and (3) how to better integrate commercial practices into Federal acquisition. To that end, the FAR Council is hosting a hybrid in-person and virtual listening session on December 4, 2024. Industry partners and the public wishing to attend in-person or virtually must register. Registrants who would like to attend in-person must do so no later than November 15, 2024. Registrants who would like to address the FAR Council must register in advance and no later than November 8, 2024. The FAR Council would like to hear the views of as many voices as practicable and will select questions/ comments keeping in mind the number received, the limited time available and the order received. Industry partners and the public are asked to only register to speak to one of these categories: • New policies the FAR Council should consider • Existing policies the FAR Council should amend • Concerns/suggestions regarding rules in process • Concerns/suggestions regarding the use of emerging technology • Concerns/suggestions regarding the process of rulemaking • Other concerns/suggestions To register to attend the listening session VIRTUALLY, do so at: https:// gsa.zoomgov.com/webinar/register/ 7117272728587/WN_ NU9vFABzQqmJ9mGtyUsNsQ. To register to attend the listening session In-Person, do so at: https:// forms.gle/yZj5RLdPdHRp5EnU8. After registering, to request to speak on one of the previously listed categories, do so at: https://forms.gle/ eFLwVcdb6K4EiKSg7. Members of the press, in addition to registering for this event, must RSVP to press@gsa.gov by November 8, 2024. Format The in-person and virtual listening session will feature panel leaders from the FAR Council. Please complete the speaking request form to provide a brief summary of your comments in a specified category no later than 5 p.m. VerDate Sep<11>2014 17:05 Oct 08, 2024 Jkt 265001 (ET) November 8, 2024. Registered participants that are selected to address the FAR Council will receive a confirmation and a timeframe to present. In-person FAR Council Listening Session Panelists will be: Jeffrey A. Koses, Senior Procurement Executive, General Services Administration John M. Tenaglia, Principal Director, Defense Pricing, Contracting, and Acquisition Policy, Office of the Secretary of Defense, Department of Defense Karla S. Jackson, Assistant Administrator for Procurement, NASA Headquarters Agenda • 9:00: Welcome and Introduction of the FAR Council • 9:15: Facilitated opportunities for attendees to engage with the FAR Council • 11:45: Closing remarks by FAR Council Special Accommodations This virtual meeting is accessible to people with disabilities using the Zoom close captioned feature. Frederick Landry, Analyst, Office of the Procurement Ombudsman, General Services Administration. [FR Doc. 2024–23343 Filed 10–8–24; 8:45 am] BILLING CODE 6820–61–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Statement of Organization, Functions, and Delegations of Authority Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: The Agency for Healthcare Research and Quality has modified its organizational structure. SUPPLEMENTARY INFORMATION: Part E, chapter E (Agency for Healthcare Research and Quality), of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (61 FR 15955–58) April 10, 1996, most recently amended at 81 FR 22271 on April 15, 2016) is amended to reflect recent organizational changes. The specific amendments are as follows: SUMMARY: PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 81915 I. Under Section E–10, Organization, delete all components and replace them with the following: A. Office of the Director. B. Center for Evidence and Practice Improvement. C. Center for Quality Improvement and Patient Safety. D. Center for Financing, Access, and Cost Trends. E. Office of Communications. F. Office of Extramural Research, Education, and Priority Populations. G. Office of Management Services. II. Under Section E–20, Functions, delete Center for Evidence and Practice Improvement, Center for Financing, Access, and Cost Trends, Center for Quality Improvement and Patient Safety, and Office of the Director in its entirety and replace with the following: Center for Evidence and Practice Improvement. Conducts and supports research on health care delivery and practice improvement across the continuum of care from prevention to chronic care management to end-of-life care. Specifically: (1) Synthesizes evidence and translates science for multiple stakeholders; (2) advances decision and communication sciences to facilitate informed treatment and healthcare decision-making by patients and their healthcare providers; (3) explores how digital healthcare research can improve clinical decision-making and health care quality; (4) catalyzes and promotes sustainability of improvements in clinical practice across health care settings through research, demonstration projects, and partnership development; (5) studies the roles that health professionals, health systems, and organizations play in the provision of health care services; (6) examines the role of health systems in improving quality and efficiency of health care services; and (7) operates the National Center for Excellence in Primary Care Research. Shall be organized into the following four divisions: Division of Evidence-Based Practice Centers: Produces evidence syntheses by conducting systematic evidence reviews using robust and rigorous methodologies and advances evidence synthesis methods to ensure scientific rigor and unbiased reviews. Division of U.S. Preventive Services Task Force: Provides scientific, administrative, and dissemination support for the independent U.S. Preventive Services Task Force, enabling the Task Force to make evidence-based recommendations on clinical preventive services. Division of Digital Healthcare Research: Utilizes advanced analytics to E:\FR\FM\09OCN1.SGM 09OCN1 khammond on DSKJM1Z7X2PROD with NOTICES 81916 Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices enhance healthcare decision-making and research how facets of the evolving digital healthcare ecosystem can best create transformational value for patients and their families in delivering safe and effective care. Division of Practice Improvement: Advances the science of clinical practice improvement, including shared decision-making; evaluates and supports innovative models of practice transformation in diverse settings; facilitates communities of learning to promote the implementation of evidence for practice improvement; and serves as a trusted source of evidence and tool development for methods, measures, and evaluation of practice improvement. Center for Financing, Access, and Cost Trends. Conducts and supports studies of the use of and expenditures for healthcare services, the sources of payment for that care, the availability and cost of health insurance, and access to healthcare. Administers large-scale surveys and develops large data sets to support health care policy and behavioral research and analysis. Shall be organized into the following four divisions: Division of Statistical Research and Methods (DSRM): Provides a wide range of statistical activities for designing and implementing the Medical Expenditure Panel Survey (MEPS) and for planning and researching to help guide and improve these data collection and analysis. Division of Research and Modeling (DRM): Conducts studies on access to, costs, and financing of healthcare services. Provides ongoing analytic support to MEPS design and implementation. Develops and maintains various simulation models, components, databases, tools, and research products that enhance the value of the AHRQ data. Utilizes these models and databases to conduct microsimulation analyses of the effects, on households and individuals, of health policies embodied in current law and the potential impacts of healthcare policies embodied in generic versions of proposed healthcare reforms. Division of Survey Operations (DSO): Oversees the MEPS data collection, processing, and distribution activities. Directs data collection for the major MEPS surveys, prepares data files for public use, and conducts workshops on the appropriate use of MEPS data. Publishes statistical briefs, research findings, and a series of methodological reports. Manages a data center for researchers that houses MEPS data and maintains liaisons with Federal and non-federal individuals and VerDate Sep<11>2014 17:05 Oct 08, 2024 Jkt 265001 organizations engaged in health services research. Division of Healthcare Delivery and Systems Research (DHDSR): Develops new evidence, tools, and measures to understand how health care is delivered in the U.S., emphasizing the roles that physicians, physician practices, hospitals, health systems, other medical professionals, and organizations play in the provision of health care services. Center for Quality Improvement and Patient Safety. Measures the performance of the U.S. health care system; identifies, promotes, and supports evidence-based research; and provides information used to improve the safety and quality of health care. Collaborates with stakeholders across the health care system to implement evidence-based practices and accelerate and amplify improvements in quality, including patient and workforce safety. Shall be organized into the following five divisions: Division of General Patient Safety: Leads research efforts on the risks and harms inherent in delivering healthcare services in various settings. Develops, tests, and facilitates understanding and use of evidence-based tools and information to improve the quality and safety of health care and reduce the risk of patient harm. Division of Patient Safety Organizations: Administers the Patient Safety Organization (PSO) Program per the Patient Safety and Quality Improvement Act 2005. Approves and oversees PSOs that apply for official federal ‘‘listing.’’ Publishes Common Formats for measuring adverse events in hospitals. Division of Healthcare-Associated Infections: Leads research studies and implementation projects that prevent, reduce, and ultimately eliminate healthcare-associated infections (HAIs) and combat antibiotic resistance. It fosters the creation of new knowledge and the generation of evidence to develop improved methods for preventing healthcare-associated infections and improving antibiotic use in multiple settings. It promotes the wide-scale implementation of effective interventions for preventing HAIs and promoting antibiotic stewardship in all these care settings. Division of Quality Measurement and Improvement: Conducts quality measurement and evaluates improvement activities to improve healthcare delivered in the United States. Seeks opportunities to integrate various measurement efforts to provide a complete picture of quality and safety. Promotes enhanced collaboration and coordination of measurement efforts, PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 including integration where possible, to serve the needs of multiple stakeholders who use measurements, such as frontline clinicians, patients, safety and quality experts, administrators, researchers, payers, policymakers, and others. Conducts focused measurement programs, including the Consumer Assessment of Healthcare Providers and Systems, Surveys on Patient Safety Culture programs, and the AHRQ Quality Indicators. Division of Healthcare Data and Analytics (DHDA): Leads the development, production, and improvement of healthcare delivery data and tools for use in research and policy analysis focused on HCUP and the supply side of the medical care market. Directs, conducts, and supports research on health care delivery and utilization to examine issues related to access, utilization, cost, safety, and quality of hospital, physician, and other services. Disseminates data, tools, and statistics to facilitate and inform public and private health policy analysis, clinical studies, and socioeconomic research. Office of the Director (OD). Provides leadership of the Agency and is responsible for planning, managing, and coordinating Agency programs and activities in fulfillment of AHRQ’s mission. Principal activities include ensuring the overall scientific integrity and objectivity of the Agency’s research and programs; directing and coordinating the Agency’s programs, research, training programs, and dissemination activities; ensuring Agency programs support Administration goals and objectives; representing the Agency within the Department, at the highest levels of Government, and to the public. Shall be organized into the following two sub-offices: Immediate Office of the Director (IOD). Provides overall leadership of the Agency and plans, manages, and coordinates the programs and activities of all AHRQ components. The IOD supports the Director and Deputy Director in achieving the Agency’s mission. Specifically, (1) provides strategic advice to the Director in support of agency priorities; (2) coordinates the legislative activities of the Agency; (3) manages the day-to-day operations of the Office of the Director and provides administrative support services; and (4) controls the flow of correspondence and official documents entering and leaving the Agency. Office of Policy, Planning, and Evaluation. Directs and coordinates AHRQ’s policy, planning, and evaluation. Specifically, (1) directs and coordinates program planning activities E:\FR\FM\09OCN1.SGM 09OCN1 Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices in fulfillment of the Agency’s mission; (2) plans and manages the program evaluation activities of the Agency, including evaluations of dissemination, training, and research programs; (3) provides support and management for the activities of the Agency’s National Advisory Council; and (4) maintains ongoing liaison with public and private sector producers and users of health services research. All delegations and redelegations of authority to officers and employees of the Agency for Healthcare Research and Quality officers and employees immediately before the effective date of this reorganization shall continue in effect pending further redelegation, provided they are consistent with this reorganization. These changes are effective upon the date of signature. Dated: October 3, 2024. Robert Otto Valdez, Director. [FR Doc. 2024–23316 Filed 10–8–24; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10142 and CMS–10203] Agency Information Collection Activities: Proposed Collection; Comment Request FOR FURTHER INFORMATION CONTACT: Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. Contents The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10142 Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDP) CMS–10203 Medicare Health Outcomes Survey Under the PRA (44 U.S.C. 3501– 3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. AGENCY: SUMMARY: khammond on DSKJM1Z7X2PROD with NOTICES collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by December 9, 2024. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number: lll, Room C4–26– 05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. VerDate Sep<11>2014 17:05 Oct 08, 2024 Jkt 265001 William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 81917 Section 3506(c)(2)(A) of the PRA requires Federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collections 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDP); Use: Medicare Advantage organizations (MAO) and Prescription Drug Plans (PDP) are required to submit an actuarial pricing ‘‘bid’’ for each plan offered to Medicare beneficiaries for approval by CMS. The MAOs and PDPs use the Bid Pricing Tool (BPT) software to develop their actuarial pricing bid. The competitive bidding process defined by the ‘‘The Medicare Prescription Drug, Improvement, and Modernization Act’’ (MMA) applies to both the MA and Part D programs. It is an annual process that encompasses the release of the MA rate book in April, the bid’s that plans submit to CMS in June, and the release of the Part D and RPPO benchmarks, which typically occurs in August. Form Number: CMS–10142 (OMB control number: 0938–0944); Frequency: Yearly; Affected Public: Private sector—Business or other forprofit and Not-for-profit institutions; Number of Respondents: 460; Total Annual Responses: 11,700; Total Annual Hours: 406,000. (For policy questions regarding this collection contact Rachel Shevland at 410–786– 3026 or rachel.shevland@cms.hhs.gov.) 2. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Medicare Health Outcomes Survey; Use: The HOS is a longitudinal patient-reported outcome measure (PROM) that assesses selfreported beneficiary quality of life and daily functioning. As a PROM, the HOS measures the impact of services provided by MAOs, whereas process and patient experience measures only provide a snapshot of activities or experiences at a specific point in time. PROM data collected by the HOS allows CMS to continue to assess the health of the Medicare Advantage population. This older population is at increased risk of adverse health outcomes, including chronic diseases and mobility impairments that may significantly E:\FR\FM\09OCN1.SGM 09OCN1

Agencies

[Federal Register Volume 89, Number 196 (Wednesday, October 9, 2024)]
[Notices]
[Pages 81915-81917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23316]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Statement of Organization, Functions, and Delegations of 
Authority

AGENCY: Agency for Healthcare Research and Quality, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality has modified 
its organizational structure.

SUPPLEMENTARY INFORMATION: Part E, chapter E (Agency for Healthcare 
Research and Quality), of the Statement of Organization, Functions, and 
Delegations of Authority for the Department of Health and Human 
Services (61 FR 15955-58) April 10, 1996, most recently amended at 81 
FR 22271 on April 15, 2016) is amended to reflect recent organizational 
changes. The specific amendments are as follows:
    I. Under Section E-10, Organization, delete all components and 
replace them with the following:

A. Office of the Director.
B. Center for Evidence and Practice Improvement.
C. Center for Quality Improvement and Patient Safety.
D. Center for Financing, Access, and Cost Trends.
E. Office of Communications.
F. Office of Extramural Research, Education, and Priority Populations.
G. Office of Management Services.

    II. Under Section E-20, Functions, delete Center for Evidence and 
Practice Improvement, Center for Financing, Access, and Cost Trends, 
Center for Quality Improvement and Patient Safety, and Office of the 
Director in its entirety and replace with the following:
    Center for Evidence and Practice Improvement. Conducts and supports 
research on health care delivery and practice improvement across the 
continuum of care from prevention to chronic care management to end-of-
life care. Specifically: (1) Synthesizes evidence and translates 
science for multiple stakeholders; (2) advances decision and 
communication sciences to facilitate informed treatment and healthcare 
decision-making by patients and their healthcare providers; (3) 
explores how digital healthcare research can improve clinical decision-
making and health care quality; (4) catalyzes and promotes 
sustainability of improvements in clinical practice across health care 
settings through research, demonstration projects, and partnership 
development; (5) studies the roles that health professionals, health 
systems, and organizations play in the provision of health care 
services; (6) examines the role of health systems in improving quality 
and efficiency of health care services; and (7) operates the National 
Center for Excellence in Primary Care Research.
    Shall be organized into the following four divisions:
    Division of Evidence-Based Practice Centers: Produces evidence 
syntheses by conducting systematic evidence reviews using robust and 
rigorous methodologies and advances evidence synthesis methods to 
ensure scientific rigor and unbiased reviews.
    Division of U.S. Preventive Services Task Force: Provides 
scientific, administrative, and dissemination support for the 
independent U.S. Preventive Services Task Force, enabling the Task 
Force to make evidence-based recommendations on clinical preventive 
services.
    Division of Digital Healthcare Research: Utilizes advanced 
analytics to

[[Page 81916]]

enhance healthcare decision-making and research how facets of the 
evolving digital healthcare ecosystem can best create transformational 
value for patients and their families in delivering safe and effective 
care.
    Division of Practice Improvement: Advances the science of clinical 
practice improvement, including shared decision-making; evaluates and 
supports innovative models of practice transformation in diverse 
settings; facilitates communities of learning to promote the 
implementation of evidence for practice improvement; and serves as a 
trusted source of evidence and tool development for methods, measures, 
and evaluation of practice improvement.
    Center for Financing, Access, and Cost Trends. Conducts and 
supports studies of the use of and expenditures for healthcare 
services, the sources of payment for that care, the availability and 
cost of health insurance, and access to healthcare. Administers large-
scale surveys and develops large data sets to support health care 
policy and behavioral research and analysis.
    Shall be organized into the following four divisions:
    Division of Statistical Research and Methods (DSRM): Provides a 
wide range of statistical activities for designing and implementing the 
Medical Expenditure Panel Survey (MEPS) and for planning and 
researching to help guide and improve these data collection and 
analysis.
    Division of Research and Modeling (DRM): Conducts studies on access 
to, costs, and financing of healthcare services. Provides ongoing 
analytic support to MEPS design and implementation. Develops and 
maintains various simulation models, components, databases, tools, and 
research products that enhance the value of the AHRQ data. Utilizes 
these models and databases to conduct microsimulation analyses of the 
effects, on households and individuals, of health policies embodied in 
current law and the potential impacts of healthcare policies embodied 
in generic versions of proposed healthcare reforms.
    Division of Survey Operations (DSO): Oversees the MEPS data 
collection, processing, and distribution activities. Directs data 
collection for the major MEPS surveys, prepares data files for public 
use, and conducts workshops on the appropriate use of MEPS data. 
Publishes statistical briefs, research findings, and a series of 
methodological reports. Manages a data center for researchers that 
houses MEPS data and maintains liaisons with Federal and non-federal 
individuals and organizations engaged in health services research.
    Division of Healthcare Delivery and Systems Research (DHDSR): 
Develops new evidence, tools, and measures to understand how health 
care is delivered in the U.S., emphasizing the roles that physicians, 
physician practices, hospitals, health systems, other medical 
professionals, and organizations play in the provision of health care 
services.
    Center for Quality Improvement and Patient Safety. Measures the 
performance of the U.S. health care system; identifies, promotes, and 
supports evidence-based research; and provides information used to 
improve the safety and quality of health care. Collaborates with 
stakeholders across the health care system to implement evidence-based 
practices and accelerate and amplify improvements in quality, including 
patient and workforce safety.
    Shall be organized into the following five divisions:
    Division of General Patient Safety: Leads research efforts on the 
risks and harms inherent in delivering healthcare services in various 
settings. Develops, tests, and facilitates understanding and use of 
evidence-based tools and information to improve the quality and safety 
of health care and reduce the risk of patient harm.
    Division of Patient Safety Organizations: Administers the Patient 
Safety Organization (PSO) Program per the Patient Safety and Quality 
Improvement Act 2005. Approves and oversees PSOs that apply for 
official federal ``listing.'' Publishes Common Formats for measuring 
adverse events in hospitals.
    Division of Healthcare-Associated Infections: Leads research 
studies and implementation projects that prevent, reduce, and 
ultimately eliminate healthcare-associated infections (HAIs) and combat 
antibiotic resistance. It fosters the creation of new knowledge and the 
generation of evidence to develop improved methods for preventing 
healthcare-associated infections and improving antibiotic use in 
multiple settings. It promotes the wide-scale implementation of 
effective interventions for preventing HAIs and promoting antibiotic 
stewardship in all these care settings.
    Division of Quality Measurement and Improvement: Conducts quality 
measurement and evaluates improvement activities to improve healthcare 
delivered in the United States. Seeks opportunities to integrate 
various measurement efforts to provide a complete picture of quality 
and safety. Promotes enhanced collaboration and coordination of 
measurement efforts, including integration where possible, to serve the 
needs of multiple stakeholders who use measurements, such as front-line 
clinicians, patients, safety and quality experts, administrators, 
researchers, payers, policymakers, and others. Conducts focused 
measurement programs, including the Consumer Assessment of Healthcare 
Providers and Systems, Surveys on Patient Safety Culture programs, and 
the AHRQ Quality Indicators.
    Division of Healthcare Data and Analytics (DHDA): Leads the 
development, production, and improvement of healthcare delivery data 
and tools for use in research and policy analysis focused on HCUP and 
the supply side of the medical care market. Directs, conducts, and 
supports research on health care delivery and utilization to examine 
issues related to access, utilization, cost, safety, and quality of 
hospital, physician, and other services. Disseminates data, tools, and 
statistics to facilitate and inform public and private health policy 
analysis, clinical studies, and socioeconomic research.
    Office of the Director (OD). Provides leadership of the Agency and 
is responsible for planning, managing, and coordinating Agency programs 
and activities in fulfillment of AHRQ's mission. Principal activities 
include ensuring the overall scientific integrity and objectivity of 
the Agency's research and programs; directing and coordinating the 
Agency's programs, research, training programs, and dissemination 
activities; ensuring Agency programs support Administration goals and 
objectives; representing the Agency within the Department, at the 
highest levels of Government, and to the public.
    Shall be organized into the following two sub-offices:
    Immediate Office of the Director (IOD). Provides overall leadership 
of the Agency and plans, manages, and coordinates the programs and 
activities of all AHRQ components. The IOD supports the Director and 
Deputy Director in achieving the Agency's mission. Specifically, (1) 
provides strategic advice to the Director in support of agency 
priorities; (2) coordinates the legislative activities of the Agency; 
(3) manages the day-to-day operations of the Office of the Director and 
provides administrative support services; and (4) controls the flow of 
correspondence and official documents entering and leaving the Agency.
    Office of Policy, Planning, and Evaluation. Directs and coordinates 
AHRQ's policy, planning, and evaluation. Specifically, (1) directs and 
coordinates program planning activities

[[Page 81917]]

in fulfillment of the Agency's mission; (2) plans and manages the 
program evaluation activities of the Agency, including evaluations of 
dissemination, training, and research programs; (3) provides support 
and management for the activities of the Agency's National Advisory 
Council; and (4) maintains ongoing liaison with public and private 
sector producers and users of health services research.
    All delegations and redelegations of authority to officers and 
employees of the Agency for Healthcare Research and Quality officers 
and employees immediately before the effective date of this 
reorganization shall continue in effect pending further redelegation, 
provided they are consistent with this reorganization.
    These changes are effective upon the date of signature.

    Dated: October 3, 2024.
Robert Otto Valdez,
Director.
[FR Doc. 2024-23316 Filed 10-8-24; 8:45 am]
BILLING CODE 4160-90-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.